• Journal of Chest Surgery
• /
• 제32권10호
• /
• pp.962-965
• /
• 1999

Carcinosarcoma of the esophagus have an interesting pathologic feature of admixture of carcinomatous and sarcomatous lesion and accounts for 0.5∼1.5% of all esophageal neoplasm. Generally, it has been reported that these have better prognosis than the squamous cell carcinoma. We have experienced two cases of carcinosarcoma occurring at the mid-esophagus. In both two cases, Ivor Lewis operation was performed and lymph node metastasis was absent. The pathologic diagnosis was confirmed as carcinosarcoma. Postoperative course was uneventful and the patients have been followed up for 3 months and 3 years, respectively, without any problems. We report these cases with a brief review of the literatures.

• Journal of Chest Surgery
• /
• 제33권1호
• /
• pp.112-115
• /
• 2000

A-13-urar-old with a history of Alport syndrome had been suffering from progressive dysphagia and postprandial vomiting for over 7 years. Exophagogram and manoemtric studies were consistent with achalasia. Barum study demonstrated marked esophageal dilatation and smooth tapered narrowing of the distal esophagus. However in spite of the medical treatment including the injection of the distal esophagus. However in spite of the medical treatment including the injection of botulinum toxin at the lesion site using an endoscope symptom did not improved and he suffered growth failure and malnutrition. Esophagectomy and esophagogastrostomy were performed to relieve the dysphagia. A firm circumferential intramural mass about 7$\times$5$\times$5 cm was found in the distal esophagus. The lumen of the esophagus was markedly dilated and esophageal wall was hypertrophied. Histologic examination of the neoplasm revealed a rather ill defined tumor tissue consisting of interlacing or whirling spindle cells without significant mitosis and esophageal leiomyo-matosis was confirmed. The patient was discharged uneventfully.

• Journal of Chest Surgery
• /
• 제29권9호
• /
• pp.1050-1053
• /
• 1996

기저세포양 편평세포암(basaloid squamous carcinoma)은 상부 기도소화기계에 발생하는 드문, 악성도가 높은 암종으로 침습성 편평세포암(invasive squamous carcinoma)이나 상피내암(carcinoma in situ) 형태의 편평상피암종성분과 밀접하게 혼재되어 있는 기저세포앞종성분(basaloid component)으로 특징 지워질 수 있다. 이런 조직학적 특성에도 불구하고 식도의 선양 낭성암(adenoid cystic carcinoma)이나 선양 낭성 분화를 보이는 암종(carcinoma with adenoid cystic differentiation)과 혼동되어 왔으나, 순수 선양 낭성암은 악성도가 기저세포양 편평세포암보다 낮아감별 진단이 중요하다. 기저세포양편평세포암의 임상적 경과는 식도의 편평세포암과 유사하다. 본 병원에서는 60세 남자의 식도 중간 113 부위에 발생한 기저세포양 편굉세포암을 수술치험하였다.

• Journal of Chest Surgery
• /
• 제31권11호
• /
• pp.1106-1109
• /
• 1998

식도의 원발성 악성 흑색종은 매우 드문 종양성 질환으로 전세계적으로 약 200례가 보고되어 있다. 저자들은 식도 악성 흑색종의 외과적 치험 1례를 문헌고찰과 함께 보고하였다. 종양은 호두알 크기의 타원형으로 중부 식도에 위치하고 있었으며, 식도-위 경계부위에 2개의 위성병변이 있었다. 종양은 조직학적 검사와 면역조직학적 검사에 의하여 식도원발의 악성 흑색종으로 확진되었다. 개흉적 식도아전절제와 2영역 림프절적출로 근치적 수술을 하였으나, 수술 7개월후 원격전이 재발이 확인되었으며 면역요법에 뚜렷한 효과를 보이지 않고 있다.

• Journal of Chest Surgery
• /
• 제28권11호
• /
• pp.1063-1066
• /
• 1995

Though leiomyoma is the most common benign esophageal tumor, it is rare in the upper third of esophagus. Recently, we experienced two cases of esophageal leiomyoma in the upper third of esophagus. The patient were a 53 year old female and a 40 year old male. On esophagoscopy, masses were found at 20\ulcorner23 cm, 22\ulcorner26 cm from upper incisor with normal overlying mucosa. Enucleation was done through a right posterolateral thoracotomy without complications.

• Journal of Chest Surgery
• /
• 제28권10호
• /
• pp.942-945
• /
• 1995

The coincidental occurrence of squamous cell carcinoma and leiomyoma in the esophagus is rare. A 56 year-old male referred to chest surgery department to evaluate the mediastinal mass which had found on a health examination. The diagnosis was confirmed esophagoscopy and surgery. We report a case of synchronous squamous cell carcinoma and leiomyoma in esophagus and reviewed references to the literature.

• Journal of Chest Surgery
• /
• 제28권3호
• /
• pp.287-292
• /
• 1995

From March 1989 to June 1994, 24 casesof esophageal cancer were treated surgically. Among 24, male was 22 cases, female was 2 cases, and the age ranged from 46 to 75, the mean was 59.8. Symptoms were dysphagia[86.9% , weight loss[65.2% and retrosternal pain or discomfort[47.8% . The tumor was located cervical esophagus in two, upper esophagus in three, middle esophagus in 12 and lower esophagus in 7. Among 24 patients, 22 were curative resection, partial esophagectomy with esophagogastrostomy[18 cases or colon interposition [3 cases , with total esophagectomy with musculocutaneous flap[1 case , with feeding jejunostomy or gastrostomy in two cases.Postoperative complications revealed 10 patients[45.4% , as followed ; pleural effusion and pneumonia in 5, passage disturbance in 4, empyema and wound infection in 3, esophagopleural fistula and sepsis in 2, anastomotic site leakage and respiratory failure in each 1. The operative mortality was 13.6 % [3/22 and causes of death were respiratory failure in 1 case and sepsis in 2 cases.During follow-up work, 8 cases died during follow-up period, mean survival time was 15.2 months in curative resection group. One year survival rate was 55.3% in resected group. Also, cancer recurrence revealed in 1 cases.

• 대한두경부종양학회지
• /
• 제34권2호
• /
• pp.81-84
• /
• 2018

Granular cell tumor is an uncommon neoplasm that can occur everywhere in the human body. Granular cell tumor of the cervical esophagus is rare. Histopathologically, granular cell tumor consists of large polygonal cells with small dark nuclei and abundant, fine, granular eosinophilic cytoplasm that show positive immunohistochemical staining using S-100 protein. Surgical excision is the treatment of choice for granular cell tumor. Recurrence is rare, but inadequate resection of granular cell tumor may cause local recurrence. We have experienced one case of granular cell tumor of the cervical esophagus that was misdiagnosed with parathyroid tumor. Therefore, we report it with the literature review.

• Journal of Chest Surgery
• /
• 제27권12호
• /
• pp.1056-1059
• /
• 1994

Small cell carcinoma is a highly malignant esophageal tumor composed of anaplastic small cells with features very similar to those of its pulmonary counterpart. The prognosis is poorer than that of squamous carcinoma of the esophagus because of its propensity of generalized spread and metastasis. Once the diagnosis of small cell carcinoma was established, surgery should be undertaken as early as possible. We have described an experience of small cell carcinoma of the lower esophagus in a 72 year old male patient with a review of the literatures regarding treatment methods and prognosis.

• Journal of Chest Surgery
• /
• 제33권9호
• /
• pp.734-737
• /
• 2000

Background: McKeown first described two autopsy cases of esophageal small cell carcinoma (SMC) in 1952; about 230 cases have since been reported in the literature. Small cell carcinoma has been reported to account for 0.4% to 7.6% of all esophageal malignancies. SMC of the esophagus as regarded as having a poor prognosis with frequent systemic dissemination. Choice of treatment remains controversial. Material and Method: From August 1987 to December 1998, a review of the records and histologic sections of 8 patients with primary small cell carcinoma of the esophagus seen in 11 years was undertaken. Result: Small cell carcinoma of the esophagus constituted 1.5% of all esophageal cancers. The median age was 61.5 years(range from 42 to 71 years). Seven patients were male, tumor was mainly located in the middle and lower thirds(6 cases) of the esophagus. Pure SMC is 5 cases, and mixed SMC is 3 cases. Operative procedure were as follow: transthoracic esophagectomy with thoracic or cervical reconstructon in 7 patients, transhiated esophagectomy with cervical reconstruction in one. The operative death was none. Adjuvant chemotherapy was performed in 7 patients except one who had poor general condition. Recurrence was observed in 4 patients(mediastinal LN, abdominal LN, SCN, bone). The overall median survival was 15.9 months. Only one patient survived for more than 5 years. Conclusion: We considered that esophageal SMC should be regarded as a systemic disease, and multimodality treatment including chemotherapy should be used. Surgery may be offered in selected patients to manage local disease as part of a chemotherapy based treatment program.